跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 32,748 条关于
“Revive Therapeutics Ltd”
全部
32,748
临床试验
11,928
药物
4,547
机构
5,101
资讯
11,172
10个月前
Revive Therapeutics Advances Bucillamine Research for Nerve Agent Countermeasure in Collaboration with Canadian Defense Agency
去年
Revive Therapeutics Focuses R&D on Bucillamine for Infectious Diseases and Nerve Agent Exposure
去年
Revive Therapeutics to Acquire DiagnaMed's Molecular Hydrogen Program for ALS and Brain Disorders
去年
Revive Therapeutics Engages Novotech for Bucillamine COVID-19 Clinical Trials in Asia-Pacific
2年前
Revive Therapeutics Advances Bucillamine Development for Long COVID Treatment Through Manufacturing Partnership
去年
FDA Grants Orphan Drug Designation to DiagnaMed's Molecular Hydrogen Therapy for ALS
6个月前
Revive Therapeutics Expands Bucillamine Patent Portfolio with North American Filings for Chemical Warfare Agent Treatment
3天前
Revive Therapeutics to Expand Bucillamine IP and Orphan Drug Portfolio Across Medical Countermeasures and Rare Diseases
去年
Protagonist Therapeutics Announces Poster Presentation on Final REVIVE Phase 2 Study ...
去年
Lumosa Therapeutics' LT3001 Shows Promise in Phase II Acute Ischemic Stroke Trial
第 1 页,共 1118 页
上一页
下一页